i-Lido-CA Trial: Intravenous Lidocaine for Cesarean Analgesia

Syrine Aguir0 个研究点目标入组 126 人开始时间: 2023年10月17日最近更新: 2024年3月4日

适应症

试验速览

暂无简介。

•Age = 18 years;
•Singleton evolving pregnancy;
•Gestational age > 35 weeks;
•Scheduled or semi-urgent cesarean section (decision-to-extraction interval >10 minutes);
•Cesarean section under spinal anesthesia;
•ASA (American Society of Anesthesiologists) Score 1 or 2;
•Abiding by a 6-hour fasting period before the procedure;
•Providing informed consent to participate in the protocol.

•Aged under 18 years;
•General anesthesia for the cesarean section;
•Emergency cesarean section;
•Presence of placental insertion abnormalities;
•Retroplacental hematoma;
•Pregnancy-related pathologies (Preeclampsia, gestational diabetes...);
•Non-cooperative, non-consenting, or having intellectual disability;
•ASA (American Society of Anesthesiologists) Score = 3;
•Contraindications for spinal anesthesia;
•Conduction disorder;
•Use of beta-blockers;
•Opioid or psychotropic addiction;
•Allergy to Lidocaine;
•Porphyria;
•Severe medical condition: renal, cardiac, or hepatic insufficiency;
•A history of seizures or convulsive neurological disease.
•Having had a conversion from spinal anesthesia to general anesthesia;
•Failure of spinal anesthesia;
•Experiencing a perioperative adverse event (anesthetic or surgical incident requiring resuscitation...);
•Onset of signs of intoxication.

发起方

Syrine Aguir